RecruitingNCT01617382

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

125 participants

Start Date

May 1, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to register the follow-up data of patients who, because of a peritoneal surface malignancy, will undergo cytoreductive surgery and HIPEC.


Eligibility

Plain Language Summary

Simplified for easier understanding

This is a registry study following patients who have undergone a procedure called HIPEC — where heated chemotherapy is delivered directly into the abdominal cavity during surgery — to treat cancers that have spread to the lining of the abdomen, in order to track outcomes and improve this specialized treatment. **You may be eligible if...** - You have been diagnosed with one of the following conditions that has spread to the lining of the abdomen: colorectal (bowel) cancer, pseudomyxoma peritonei (a slow-growing mucus-producing condition in the abdomen), or peritoneal mesothelioma (cancer of the abdominal lining) - You are planned to undergo or have undergone surgery plus HIPEC treatment **You may NOT be eligible if...** - You have a different type of cancer not listed above - You have not undergone or are not planned to undergo the HIPEC procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Clinics Gasthuisberg

Leuven, Flemish Brabant, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01617382


Related Trials